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Summary
This study has identified horizontally acquired
genomic regions of enterohaemorrhagic Escherichia
coli O157:H7 that regulate expression of the type III
secretion (T3S) system encoded by the locus of
enterocyte effacement (LEE). Deletion of O-island 51, a
14.93 kb cryptic prophage (CP-933C), resulted in a
reduction in LEE expression and T3S. The deletion
also had a reduced capacity to attach to epithelial
cells and significantly reduced E. coli O157 excretion
levels from sheep. Further characterization of O-island
51 identified a novel positive regulator of the LEE,
encoded by ecs1581 in the E. coli O157:H7 strain Sakai
genome and present but not annotated in the E. coli
strain EDL933 sequence. Functionally important resi-
dues of ECs1581 were identified based on phenotypic
variants present in sequenced E. coli strains and the
regulator was termed RgdR based on a motif demon-
strated to be important for stimulation of gene expres-
sion. While RgdR activated expression from the LEE1
promoter in the presence or absence of the LEE-
encoded regulator (Ler), RgdR stimulation of T3S
required ler and Ler autoregulation. RgdR also con-
trolled the expression of other phenotypes, including
motility, indicating that this new family of regulators
may have a more global role in E. coli gene expression.
Introduction
Escherichia coli strains are usually present in the flora of
mammalian gastrointestinal (GI) tracts and many are
considered non-pathogenic. However, some strains are
associated with serious intestinal and extra-intestinal
infections. The main differences among strains of these
different pathotypes can be attributed to the acquisition of
genetic information from mobile genetic elements, in par-
ticular bacteriophage (Kaper et al., 2004). Bacteriophage
integration and recombination not only leads to phage
evolution, but is a key driver in the acquisition of virulence
attributes in enteric bacteria, and of the complex regulatory
networks that control their expression. Enterohaemor-
rhagic E. coli (EHEC) contain prophage-encoded Shiga
toxins and are associated with severe GI and systemic
disease in humans (Nataro and Kaper, 1998; Karmali,
2004). Ruminants are considered to be the most important
reservoirs for EHEC, particularly cattle and sheep which
shed the organism in their faeces (La Ragione et al., 2009).
The predominant pathogenic serotype in North America,
parts of Asia and the UK is O157:H7 (Armstrong et al.,
1996; Besser et al., 1999; Caprioli et al., 2005).
Studies on EHEC O157:H7 have shown that the geno-
typic diversity among different strains is largely attributable
to bacteriophage-related DNA fragments (Ohnishi and
Hayashi, 2002; Zhang et al., 2007; Asadulghani et al.,
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2009). In EHEC O157:H7 strain EDL933, these horizon-
tally acquired elements have been termed O-islands (OIs)
and include both fully functional and cryptic prophages
(Perna et al., 2001). The locus of enterocyte effacement
(LEE) encodes a type III secretion (T3S) system, an essen-
tial virulence factor for EHEC that allows the direct injection
of bacterial effector proteins into host cells to subvert host
cell signalling pathways and promote bacterial attachment
(Kenny et al., 1997; Hemrajani et al., 2010; Newton et al.,
2010). While T3S has been shown to be critical for EHEC
O157:H7 colonization in the ruminant host (Naylor et al.,
2005), levels of T3S can vary significantly among different
EHEC isolates (Son et al., 2002; Roe et al., 2003; Rashid
et al., 2006; Yang et al., 2009). Such variation in T3S
regulation may have important implications for bacterial
persistence and shedding in the bovine host and for human
infection (Chase-Topping et al., 2008). Recent studies
comparing EHEC O157:H7 genome sequences have iden-
tified three lineages of the organism (Kim et al., 1999;
Zhang et al., 2007). While all lineages can be isolated from
cattle, lineage I (LI) and lineage I/II (LI/II) strains are more
frequently associated with human clinical disease than
lineage II (LII) strains. Further, EHEC O157:H7 strains
associated with outbreaks of severe illness in the USA
have been shown to belong to a single subtype of LI/II,
designated SNP clade 8 (Manning et al., 2008; Laing et al.,
2009). Several studies have attempted to understand the
genetic basis for the apparent differences in the epidemi-
ology and virulence among EHEC O157:H7 genotypes,
and recent studies have shown that LI and LI/II strains
produce higher levels of Shiga toxins than bovine-
associated LII strains (Zhang et al., 2010). Similarly, hyper-
virulent SNP clade 8 strains have been shown to have
higher levels of LEE expression than EHEC O157:H7
strain Sakai from SNP clade 2 (Abu-Ali et al., 2010).
A large number of factors have been shown to influence
expression of LEE in both enteropathogenic E. coli (EPEC)
and EHEC (Tree et al., 2009; Kendall et al., 2010). In both
pathotypes, the LEE-encoded regulator (Ler) is expressed
from the first LEE operon (LEE1) and is required to activate
expression of all five main LEE operons (LEE1–5) (Elliott
et al., 2000; Sharma and Zuerner, 2004). However, at
higher concentrations, Ler is considered to be repressive
at LEE1 (Berdichevsky et al., 2005; Yerushalmi et al.,
2008). To date, most of the genetic and environmental
control of T3S has been shown to occur through LEE1 and
Ler activation, including an activator and repressor combi-
nation within the LEE, GrlA and GrlR, which are involved in
the reciprocal regulation of LEE and flagella expression
(Barba et al., 2005; Iyoda et al., 2006; Huang and Syu,
2008; Jimenez et al., 2010; Islam et al., 2011;). In EPEC,
LEE expression is thought to be positively regulated by the
plasmid-encoded regulator C (PerC) locus and a series of
PerC homologue (Pch) proteins; encoded by pchA–E and
pchX in EHEC O157:H7. These genes are usually associ-
ated with cryptic prophage regions encoding effector pro-
teins that are exported by the T3S system and the Pch
regulators co-ordinate the expression of these horizontally
acquired effectors with the LEE-encoded T3S system
(Iyoda and Watanabe, 2004; Porter et al., 2005; Abe et al.
2008; Yang et al., 2009).
The aim of the present study was to identify OIs of
EHEC O157:H7 that cross-talk with the T3S system. An
OI-51 deletion mutant was shown to have lower levels of
LEE expression in vitro and subsequent testing demon-
strated that this genomic island contributes to ruminant
colonization and persistence. A novel regulator, termed
RgdR, was identified on OI-51 and shown to control both
LEE expression and motility. The mechanism of RgdR
activation of LEE was investigated.
Results
T3S screening of EHEC O-island mutants
Initial screening identified a subset of OIs with the capac-
ity to either repress or activate T3S in EHEC strains
EDL933 and TUV93-0 (Shiga toxin-negative derivative
strain of EDL933). For example, TUV93-0 derived
mutant’s DOI-47, DOI-76 (Fig. 1A) and DOI-141 (Fig. 1B)
all had levels of T3S above that of the wild-type parent,
suggesting repression by these islands, while DOI-51
(Fig. 1A) and DOI-133 (Fig. 1B) mutants had reduced
levels of T3S, suggesting activation by these islands. In
the present study, we focused on the potential signifi-
cance of OI-51 for colonization and how it controls T3S as
variation in this region has been reported to impact on
LEE regulation (Yang et al., 2009).
Deletion of OI-51 leads to reduced colonization and
shedding levels of E. coli O157 strain TUV93-0 in vivo
In order to assess the importance of OI-51 for colonization
of ruminants, the OI-51 deletion and the parent strain
were co-administered in an established ovine colonization
model (Wales et al., 2001). The OI-51 deletion was
marked with a chloramphenicol resistance cassette and
the parent strain for resistance to nalidixic acid allowing
direct plating and enumeration of the two strains from
faeces. Six animals were orally dosed with the two strains,
with only one animal failing to be properly colonized
(< 20 cfu g-1 faeces from the daily counts) (Fig. 2A). For
the remaining five animals the estimated relative total
levels of the mutant excreted from day 5 onwards, to
remove inoculum effects, were estimated with a statisti-
cally significant reduction demonstrated for the mutant
(P = 0.006, Fig. 2B) indicating that OI-51 is important for
colonization and persistence in the ruminant GI tract.
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OI-51 sequence analysis
Initial phenotypic screening indicated that an EHEC
O157:H7 DOI-51 mutant has reduced levels of T3S. OI-51
is a 14.93 kb cryptic prophage designated as CP-933C in
EHEC strain EDL933 and Sp7 in EHEC strain Sakai
(Hayashi et al., 2001) (Fig. 3). The composition of this
cryptic prophage varies in other referenced E. coli
genomes, including E. coli CFT073 and ED1a (Fig. 3).
Analysis of OI-51/Sp7 genomic structure shows it to be an
unusual and highly degraded prophage comprised mainly
of P4 phage remnants. The majority of the open reading
frames annotated in OI-51/Sp7 are hypothetical although
several share features with known proteins, including a
P4 integrase (similar to CP4-like integrase and integrase
used for 933L and LEE PAI); a P4-like excisionase (Xis);
a replication gene similar to the P4 a gene; a putative
DNA binding protein similar to P4 ORF88 (AlpA); a puta-
tive single-stranded DNA binding protein (ssDNA); a puta-
tive transcriptional activator similar to PerC (PchE); and
phage structural genes.
ECs1581 is a positive regulator of T3S in EHEC
O157:H7
Systematic analysis of cloned OI-51 regions demon-
strated that a 5 kb region (z1835–z1843) was able to
rescue T3S in the TUV93-0 DOI-51 mutant (Fig. 4A) when
expressed from low copy number vector pWSK29
(pZ1835–43) (Table S1). Deletions across this fragment
indicated that a region between z1841 and z1842 was
required for this activation (data not shown). From the
Sakai annotation (Fig. 3), this region does contain an
open reading frame, ecs1581, the identical sequence
being present but not annotated in the EDL933 sequence.
Deletion of ecs1581 by allelic replacement with a resis-
tance cassette significantly reduced T3S levels in a
TUV93-0 background. Further, the reduced levels of T3S
in both the Decs1581 and DOI-51 mutants could be
complemented by in trans expression of ecs1581 from a
low copy number plasmid (pECs1581) (Fig. 4B and C). In
line with the animal colonization data, deletion of OI-51
reduced adherence of E. coli O157 to bovine epithelial
cells and could be complemented by ecs1581 expressed
in trans (Fig. S1). We have therefore been able to identify
ecs1581 as a new regulator in EHEC that is able to
stimulate T3S and adherence.
ECs1581 is predicted to be a small protein of 99 amino
acids with a molecular mass of 11.704 kDa and a pI of
10.09. ECs1581 has no significant sequence similarity
with any known protein although it does have a very short
section of homology with the spacer region of Ler that
bridges the known protein–protein interaction domain of
Ler with its DNA binding domain (Mellies et al., 2008).
However, there is no significant homology of ECs1581
with these functional regions of Ler (Fig. S2).
Fig. 1. Screening of EHEC O157:H7 O-island (OI) mutants for altered levels of T3S. SDS-PAGE gels showing culture supernatant secretion
profiles for EHEC strain TUV93-0 and a selection of 24 isogenic deletion strains. Parent strain TUV93-0 also acted a positive control for T3S
and a T3S system mutant (DLEE1–3) provided a negative control for secretion. OI deletions are as defined with reference to the original
designations in Perna et al. (2001). The translocon protein bands are indicated, EspB/D and EspA as well as BSA which was added as a
loading control to rule out the precipitation process as a source of variation and to act as a co-precipitant. Strains were cultured in
MEM-HEPES to an OD600 of 1.0 and culture supernatants were TCA-precipitated, separated by SDS-PAGE and stained with Colloidal blue as
described in Experimental procedures.
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Distribution of ECs1581 in E. coli strains
Sequence analysis of ECs1581 variants in different line-
ages of EHEC O157:H7 showed the core region of this
protein (amino acids 20–68) to be highly conserved; with
distinct lineage-specific amino acid substitutions at the
N- and C-termini (Fig. 5A). Interestingly, this sequence
divergence was specific to LI EHEC O157 by comparison
with LII and LI/II (Fig. 5A). Similar analyses of sequences
immediately upstream of ecs1581 showed divergence
Fig. 2. OI-51 contributes to ruminant colonization. Six animals were orally dosed with both wild-type (WT) (TUV93-0) and DOI-51 EHEC
O157:H7 strains as described in Experimental procedures.
A. Levels of both strains were determined daily from faecal samples. ‘PosE’ are samples that were positive for the strain following broth
enrichment; ‘NegE’ samples were negative following broth enrichment.
B. The cumulative shedding levels for each animal and strain were estimated for colonized animals from day 5 onwards to avoid inoculum
effects. One animal was excluded from the analysis that was not properly colonized by either strain (< 20 cfu per gram of faeces). The
different symbols represent individual animals and allow direct comparison of the two strains in each animal. The right-hand panel of the graph
shows the percentage mean decrease of the mutant strain by comparison with the WT. The difference in cumulative shedding levels in the five
colonized animals was assessed by a one-sample t-test compared to a null hypothesis of 0 change. The data were log10 transformed data to
normalize the values, and the difference was statistically significant (P = 0.006).
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between these lineages (data not shown) which could
potentially impact ecs1581 expression levels. Ortho-
logues of ECs1581 were also found in sequenced non-
O157 EHEC strains (O103:H2, O26:H11 and O111:H-); in
EPEC strain O55:H7; newborn meningitis E. coli (NMEC)
strain IHE3034; enteroaggregative E. coli (EAEC) strain
O42; atypical EPEC strain E110019; uropathogenic E. coli
(UPEC) strains CFT073 (O6:K2:H1) and IAI39 (O7:K1);
Shigella spp and commensal E. coli strain ED1a (O81); all
with > 77% homology over a region of 99 amino acids (i.e.
full-length ECs1581) (Table S2). Multiple divergent copies
of ecs1581 were also present in the chromosomes of
strains harbouring this regulator and these are also
detailed in Table S2. ECs1581 contains a tri-peptide
arginine-glycine-aspartate (RGD) motif (amino acids
20–22, Fig. 5B) which may be important for mediating
protein–protein interactions based on previously estab-
lished functions of this motif (D’Souza et al., 1991).
ECs1581 and orthologous protein C1493 (UPEC) can
activate T3S and repress motility in EHEC and UPEC
Given the diversity of E. coli strains that harbour
sequence-related variants of ECs1581, its prevalence
and divergence among different EHEC lineages, and the
fact that not all strains with this regulator harbour a LEE-
encoded T3S system, we wanted to investigate the func-
tionality of a subset of these protein variants by testing
their effects on T3S and the related but more ubiquitous
flagella system.
The UPEC CFT073 variant C1493 has 83% sequence
similarity to ECs1581 (Fig. 5B) and is also encoded on a
cryptic prophage (CP073-3) that is inserted in an identical
location on the chromosome as CP-933C (OI-51/Sp7)
(Mobley et al., 1990; Perna et al., 2001; Welch et al.,
2002). c1493 was cloned into the low copy number plasmid
pWSK29 to create expression plasmid pC1493 and this
was assessed for its effects on T3S levels following
induced expression in an EHEC ecs1581 mutant. Expres-
sion of pC1493 rescued T3S demonstrating that the vari-
ants are functionally interchangeable, despite UPEC
lineages not harbouring a LEE-encoded T3S system
(Fig. 5C).
To investigate motility, a c1493 mutant was constructed
in UPEC strain CFT073 and examined in soft agar follow-
ing in trans expression of c1493 and ecs1581; in the
reciprocal manner motility was examined in a EHEC
Fig. 3. Organization of OI-51 from E. coli O157 and nucleotide
sequence homology with related regions from E. coli ED1a and
E. coli CFT073. The E. coli O157 sequence used for the
representation and analysis was from the Sakai strain and the
region shown is between the chromosomal co-ordinates:
1594585–1610169 which lie between ycdF and phoQ of E. coli
K-12 MG1655. The partially homologous region from E. coli
CFT073 (chromosomal co-ordinates: 1377764–1393349) lies in the
same chromosomal location. The related prophage in E. coli ED1a
lies between ydgD and ydgG (chromosomal co-ordinates:
1740689–1756274). The selected regions were compared by
BLASTn; regions and level of homology are indicated by the grey
shading with genes encoding RdgR (ECs1581 in Sakai) and
homologues (ECED1_1787 in ED1a and C1493 in CFT073) shown
in orange. Other characterized genes are annotated as shown with
ssDNA indicating a conserved gene in the three regions that is
predicted to encode a single-stranded DNA binding protein.
Fig. 4. Identification of ecs1581 as a positive regulator of T3S.
A. SDS-PAGE gel showing complementation of T3S in an EHEC DOI-51 strain expressing a cloned OI-51 fragment containing genes
z1835-z1843 (pZ1835-pZ1843). The empty vector alone acted as a control (pWControl).
B. SDS-PAGE gel showing the T3S profiles for the parent strain TUV93-0 and DOI-51 mutant expressing pECs1581 or pWControl.
C. SDS-PAGE gel showing the T3S profiles for parent strain TUV93-0, DOI-51 and a Decs1581 mutant expressing pZ1835–Z1843, pECs1581
or pWControl. Protein samples were prepared and analysed as described in Experimental procedures.
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ecs1581 mutant strain with in trans expression of the two
variants. Although only subtle differences in motility were
observed for wild-type and mutant constructs in both
EHEC and UPEC (Fig. 5D), the in trans and presumably
higher level expression of the two variants downregulated
motility, a phenotype that was not observed for the con-
trol strains expressing the empty vector (pWControl)
(Fig. 5D).
In EHEC, GrlA is an established regulatory protein
encoded by the LEE that positively regulates ler transcrip-
tion and LEE gene expression; and negatively regulates
motility in a feedback loop with the repressor GrlR (Iyoda
et al., 2006). Although unlikely given our observations in
EHEC and UPEC, we wanted to rule out the possibility
that in EHEC, ecs1581 may be acting reciprocally on T3S
and flagella via grlA. We therefore analysed T3S and
motility in a grlA::Tn mutant (Table S1) with and without
induced expression of ecs1581 from a low copy number
plasmid. As expected, T3S levels were reduced in the
grlA::Tn mutant compared with the parent strain (Fig. 5E).
Induced expression of ecs1581, however, was able to
increase T3S levels in the grlA::Tn mutant (Fig. 5E), indi-
cating that ecs1581 activation of T3S is mediated inde-
pendently of grlA. Further, induced expression of ecs1581
in the grlA::Tn mutant downregulated motility in this strain
(data not shown). Other regulators of both T3S and motil-
Fig. 5. Sequence comparison of ECs1581 variants in E. coli.
A. Multiple alignment of the predicted amino acid sequences of ECs1581 in different lineages of O157:H7. Residue divergence specific to
lineage I EHEC O157:H7 isolates is marked by a pink shaded box.
B. Multiple alignment of EHEC variant ECs1581 (EDL933/Sakai) with commensal variant ECED1_1787 (ED1a) and UPEC variant C1493
(CFT073). The RGD motif is at amino acid position 20–22. Residue divergence between the strains is indicated.
C. SDS-PAGE gel showing stimulation of T3S in an EHEC Decs1581 mutant expressing EHEC ECs1581 (pECs1581) or UPEC C1493
(pC1493) from a low copy number plasmid. pWControl alone in the ecs1581 mutant was used as a negative control strain. TCA-precipitated
culture supernatants were analysed as described previously in Experimental procedures.
D. Analysis of motility repression in an EHEC Decs1581 and UPEC Dc1493 deletion background expressing pECs1581, pC1493 or pWControl.
Motility was assessed as described in Experimental procedures.
E. SDS-PAGE gel showing T3S profile for EHEC strain ZAP193 and isogenic DgrlA::Tn mutant expressing pECs1581 or pWControl. Strains
were cultured in DMEM to an OD600 of 1.0 and culture supernatant proteins were analysed exactly as described for strains grown in
MEM-HEPES.
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ity include QseB-C (Hughes et al., 2009; Kostakioti et al.,
2009), although RgdR was able to significantly increase
T3S levels in a TUV93-0 DqseC mutant (data not shown)
indicating it does not act via this pathway.
Commensal orthologue ECED1_1787 is unable to
stimulate T3S or repress motility in EHEC
Commensal strain ED1a (a close relative of UPEC strain
CFT073; phylogenetic group B2) also harbours an
orthologue of ECs1581, ECED1_1787, which has 94%
sequence similarity (Fig. 5B) (Clermont et al., 2008; Jau-
reguy et al., 2008; Touchon et al., 2009). Despite having
the highest known homology to ECs1581, even compared
to other EHEC O157:H7 variants, commensal protein
ECED1_1787 was unable to activate T3S or repress
motility following induced expression (pECED1_1787) in
an EHEC ecs1581 mutant strain (Fig. 6A). This was
informative as there are only six amino acid differences
between ECs1581 and ECED1_1787 (Fig. 5B); and by
the finding that C1493 has this capacity despite its lower
homology to ECs1581 (83% versus 94% respectively).
The residue divergence in ECED1_1787 by comparison
to ECs1581 maps to the following residues: D10A, R20C,
Q27K, K35N, H45R and R61D (amino acids 1–99)
(Fig. 5B). Interestingly, two of these changes occur within
Fig. 6. Effects of natural and engineered variants of ECs1581 on T3S and motility.
A. SDS-PAGE gel showing T3S levels in EHEC strain TUV93-0 and Decs1581 mutant expressing wild-type and engineered variants of
commensal protein ECED1_1787 from a low copy number plasmid (pECED1_1787, pECED1_1787C20R and pECED1_1787N35K).
pWControl in the ecs1581 mutant strain was used as a negative control and wild-type variants pECs1581 and pC1493 were included as a
reference for high T3S levels.
B. Analysis of motility in strain TUV93-0 and Decs1581 mutant expressing pECED1_1787, pECED1_1787C20R, pECED1_1787N35K or
pWControl.
C. SDS-PAGE gel showing T3S levels in strain TUV93-0 and Decs1581 mutant expressing wild-type and engineered variants of ECs1581 from
a low copy number plasmid (pC1493, pECs1581, pECs1581R20C, pECs1581R20C20N, pECs1581K35N, pECs1581R20C + K35N,
pECs1581R20C + D10A, pECs1581R20C + H45R, pECs1581R20C + R61D, pECs1581R20C + Q27K and pWControl).
D. Analysis of motility in the same strain set. Analysis of culture supernatants and motility was carried out as described in Experimental
procedures.
The motility figures (B and D) are composite images from photographs of motility agar plates inoculated with the strain of interest. The same
images are used for the wild types and controls in B and D.
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predicted domains with a D10A substitution in a putative
N-myristylation motif (amino acids 7–12), and an R20C
substitution in the EHEC-conserved RGD motif (amino
acids 20–22) (Fig. 5B). Like ECED1_1787, C1493 has a
D10A but harbours an RGD motif as in ECs1581
(Fig. 5B).
Amino acid substitutions in ECs1581 and ECED1_1787
alter their regulation of T3S and motility
Based on the functional differences demonstrated for the
ECs1581 and ECED1_1787 proteins, a series of recipro-
cal substitutions in proteins ECs1581 and ECED1_1787
were constructed by site-directed mutagenesis and their
effects on T3S and motility assessed in an EHEC ecs1581
mutant. A single C20R mutation in protein ECED1_1787
(pECED1_1787C20R) was sufficient to enable this
variant to now activate T3S and repress motility (Fig. 6A).
An ECED1_1787 C20R + N35K double mutation
(pECED1_1787C20R + N35K) did not increase T3S
levels over the single C20R change (Fig. 6A). Strikingly,
induced expression of ECED1_1787C20R severely
repressed motility (Fig. 6B). This shift in phenotype
between wild-type ECED1_1787 and engineered variant
ECED1_1787C20R was intriguing as induced expression
of ECED1_1787 in the same strain background, if any-
thing, increased motility. A K35N substitution in ECs1581
(ECED1_1787N35) attenuated its stimulation of T3S in an
EHEC ecs1581 mutant when induced (pECs1581K35N)
from a low copy number plasmid (Fig. 6C). Surprisingly,
an R20C change in the EHEC-conserved RGD motif
(ECED1_1787C20) slightly increased T3S levels follow-
ing induced expression (pECs1581R20C) in this back-
ground, and this engineered variant was also more
repressive for motility than wild-type ECs1581 (Fig. 6C
and D). A further R20C20N mutation in this same RGD
motif, however, did reduce T3S levels compared to wild-
type ECs1581 (Fig. 6C). Although the small size of RgdR
means that some changes could affect protein conforma-
tion and stability, these results highlight the functional
importance of residue 20 and other targeted combinations
for the regulatory activities of this novel regulator.
Mechanism of ECs1581 activation of T3S
To examine how ECs1581 activates T3S, its capacity to
stimulate a plasmid-encoded LEE1–GFP transcriptional
fusion was studied in different genetic backgrounds. Popu-
lation fluorescence levels from the LEE1 fusion were
reduced significantly in an ecs1581 mutant (Fig. 7A). Ler,
expressed from LEE1, is required for autoregulation of
LEE1 and activation of the remaining LEE operons leading
to T3S. We determined whether ECs1581 was able to
stimulate LEE1 expression in the absence of ler autoregu-
lation. Population fluorescence levels from the LEE1
reporter were determined in EHEC strains ZAP198 (WT,
Table S1) and ZAP1004 (Dler, Table S1) following induc-
tion of ecs1581 (pECs1581) (Fig. 7B and C). ECs1581 was
able to stimulate LEE1 expression in the absence of ler
(Fig. 7C). To determine if ECs1581 regulation of LEE1
expression in EHEC is direct or indirect, electrophoretic
mobility shift assays (EMSA) were carried out using a
291 bp LEE1 promoter fragment (-288 to +3) and purified
ECs1581. While it was evident that the protein bound to the
DNA in a concentration-dependent manner (Fig. S3),
ECs1581 also bound to the control DNA fragment, indicat-
ing a lack of specificity to this interaction. Of note was the
finding that the commensal variant ECED1_1787, which
was unable to activate T3S, was unable to bind the same
LEE1 promoter fragment indicating that the regulatory
activity of ECs1581 may require DNA binding (Fig. S3).
In order to confirm that ECs1581 stimulates T3S
through activation of the Ler autoregulatory cascade, a
strain (ZAP1327, Table S1) was constructed in which the
LEE1 promoter was replaced by a cassette that allowed
constitutive expression of ler, removing the normal
transcriptional regulation of LEE1 including sequences
required for ler autoregulation (Mellies et al., 2008;
Yerushalmi et al., 2008). Constitutive ler transcription in
this replaced promoter strain was confirmed by RT-PCR
(Fig. 7E). There was, however, no detectable T3S from
this strain (Fig. 7F). Induced Ler expression in this back-
ground was able to stimulate T3S but this was not the
case for induced ECs1581. ECs1581 induction of the
LEE1 reporter fusion in this strain background was detect-
able but remained at a constant level throughout the
growth curve (Fig. 7D). This was in stark contrast to
the activation kinetics measured for the LEE1 fusion in
the strain with an unaltered LEE1 promoter on the
chromosome. In this wild-type background, the stimula-
tion of the LEE1 fusion increased exponentially with
optical density, whereas this increase was restricted in the
strain with a replaced LEE1 chromosomal promoter.
Therefore, stimulation of T3S by ECs1581 occurs through
initial activation of transcription from the LEE1 promoter,
leading to induction of the Ler autoregulatory cascade that
in turn promotes expression of the remaining LEE
operons and T3S.
Discussion
The contribution of bacteriophages to intra- and inter-
species bacterial evolution and adaptation are well docu-
mented. Enterobacteriaceae in particular are exposed to
a plethora of phages in the mammalian GI tract and many
of these phages carry additional genetic information that
allow the host bacteria to adapt to local environments
and occasionally cause disease. EHEC is an important
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attaching and effacing pathogen that can cause serious
complications in at-risk individuals due to the production
of phage-encoded Shiga toxins. T3S is an essential viru-
lence factor for EHEC which is required for successful
colonization of the ruminant host. This virulence secretion
system is encoded by the LEE pathogenicity island and
prophage-encoded effector proteins are able to utilize this
system to be exported directly into host cells to sabotage
host communication pathways and promote bacterial
colonization.
In this study, a number of prophage deletions (OIs)
were examined for their effect on T3S levels in order to
identify horizontally acquired regions that cross-talk with
this essential colonization system. Of the 24 OI mutants
studied in TUV93-0 (excluding the LEE1-3 deletion), five
had lower levels of T3S (Fig. 1A and B), including OI-51.
OI-51 is a 14.93 kb region in EDL933/TUV93-0 and
15.46 kb in the sequenced Sakai strain. Variations of this
island are present in all EHEC O157:H7 strains as well as
non-O157 EHEC strains, but also in specific UPEC,
NMEC and commensal E. coli strains that do not contain
a LEE-encoded T3S system. OI-51 in EDL933 contains a
predicted 22 open reading frames, with a subset indicat-
ing P4 ancestry. Deletion of OI-51 reduced persistence in
competitive ruminant colonization experiments indicating
the potential importance of this region.
Through a combination of deletion and complementa-
tion analyses, ecs1581 was identified as a gene able to
restore T3S levels in both the OI-51 and ecs1581
mutants. Three lineages of EHEC O157:H7 have been
proposed based on genome sequences (Kim et al., 1999;
Zhang et al., 2007). In the present study, two main
sequence types of ECs1581 were identified, LI and LII &
LI/II, the latter having identical protein-coding sequences.
EHEC O157:H7 lineage-specific variants of ECs1581 (LI)
from strains TW14539 (LI/II) and 96788 (LII) were cloned
and assessed for their effects on T3S and motility. All the
variants were able to induce T3S and repress motility,
although slight variation in induction levels was observed
(Fig. S4A and B). Sequences immediately upstream of
these two variants also differ, but it is not known if expres-
sion levels of these two variants differ as these were not
assessed in this study. Variation in activity and/or expres-
sion of ECs1581 could therefore contribute to differ-
ences in T3S expression demonstrated between EHEC
O157:H7 strains (Son et al., 2002; Roe et al., 2003;
Rashid et al., 2006; Yang et al., 2009). We also note that
genetic variability among the different EHEC O157:H7
lineages are associated with regions adjacent to pchD
and pchE genes on OI-43/48 (the tellurite resistance and
adhesin-conferring islands) and OI-51 respectively
(Zhang et al., 2007 and Yang et al., 2009).
Variants of the protein from different E. coli strains
exhibited markedly different capacities to regulate T3S. A
variant present in the commensal strain ED1a did not
activate T3S and contains an R20C (CGD) substitution in
the EHEC-conserved RGD motif. Replacement of this
residue to generate an RGD motif in the commensal
variant produced a protein that now had the capacity to
activate T3S. Based on this we have termed the EHEC
regulator RgdR. It was interesting to note that regardless
of the effect on T3S, all variants in RgdR had a marked
impact on motility. In general, there was an inverse cor-
relation between T3S and motility that was also apparent
for several of the engineered variants. However, there
were clear exceptions to this, for example ECs1581
R20C + K35N had a weak capacity to activate T3S yet
unusually, showed the strongest capacity to inhibit
motility. Additional work confirmed that this regulation of
T3S and motility was independent of grlA, previously
demonstrated to repress motility on induction of T3S
(Iyoda et al., 2006). RgdR is therefore identified as a
novel regulator able to co-ordinate T3 and motility
expression. Also of note was the finding that expression of
different variants could increase bacterial binding to
Congo red (Fig. S4C). Although the mechanism of this
Congo red binding was not investigated in this study,
recent work by Lee et al. (2011) has demonstrated that
EDL933 is able to produce curli fibres. Taken together, the
pleiotropic phenotypes displayed by RgdR including on
Fig. 7. ECs1581 stimulates T3S via LEE1.
A. Measurement of LEE1 promoter activity in EHEC strain TUV93-0 and isogenic Decs1581 mutant. A 428 bp LEE1 promoter fragment (-444
to -16 upstream from the ler ATG start codon) was cloned into the promoter-less green fluorescence protein (GFP) plasmid pKC26 to create
transcriptional fusion plasmid pLEE1–GFP. Strains transformed with this reporter were cultured in DMEM and the fluorescence produced by
each bacterial population measured every 60 min as described in the Experimental procedures. Corresponding OD600 measurements were
taken at each time point and plotted against the mean fluorescence intensity values for each strain. The promoter-less plasmid pKC26 in each
strain background acted as a control.
B. Measurement of the pLEE1–GFP reporter and control plasmids in EHEC strain ZAP198 (Table S1) with and without induced expression of
ecs1581 (pECs1581) from low copy number plasmid pWSK29.
C. Measurement of the pLEE1–GFP reporter and control plasmids in strain ZAP198Dler (ZAP1004, Table S1) with and without induced
expression of pECs1581.
D. Measurement of the pLEE1–GFP reporter and control plasmids in strain ZAP198 with a constitutive LEE1 promoter (ZAP1327, Table S1)
with and without induced expression of pECs1581.
E. RT-PCR measurement of ler expression levels in EHEC strains ZAP198, ZAP1004 and ZAP1327.
F. Western blot of EspD secretion by EHEC Decs1581 and the replaced LEE1 promoter mutant (ZAP1327) trans expressing Ler (pLer) or
ECs1581 (pECs1581) from low copy number plasmids.
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T3S, motility and cell surface charge suggests it may play
a more global role in the cell. This would explain the
presence of variants of this regulatory protein in strains
without a LEE-encoded T3S system. Future work will
address the regulons of RgdR in EHEC O157:H7 and
strains not harbouring a LEE pathogenicity island.
RgdR was able to stimulate LEE1 expression indepen-
dently of Ler and required a normal LEE1 promoter region
for this activation. A construct that resulted in constitutive
expression of LEE1 could be induced to secrete EspD by
increased expression of Ler in trans but not by induced
expression of RgdR in trans. In this background, RgdR
was limited in its capacity to induce a LEE1–GFP reporter
fusion construct. An explanation for this is that even
though RgdR can activate the LEE1 promoter in the
absence of Ler, Ler expression and the Ler auto-induction
cycle is required for the activation of T3S as Ler, and not
RgdR, activates transcription of LEE2-5 encoding the T3S
system and secreted proteins. One explanation for the
data is that ECs1581 could inhibit Ler autorepression at
the LEE1 promoter. It has been proposed that high Ler
levels allow binding of Ler to a low affinity site which may
repress transcriptional activation. The kinetics of LEE1
activation in the presence of induced ECs1581 would fit
this model. Repeated attempts to purify functional Ler to
test possible interactions were unsuccessful. We note that
ECs1581 does share homology with Ler over a linker
region (Fig. 4D) that could be involved in this interaction.
RgdR did demonstrate a low affinity and non-specific
interaction with DNA (Fig. S3), a property that was absent
from the ECED_1787 variant that did not stimulate T3S.
We propose that RgdR may act as a co-factor with one or
more regulators of T3S (Tree et al., 2009; Kendall et al.
2010) to control transcription from the LEE1 promoter.
One regulatory network investigated was the quorum-
sensing two-component system, QseBC, as this controls
both T3S and motility (Hughes et al., 2009; Kostakioti
et al., 2009). However, RgdR was able to significantly
increase T3S levels in a TUV93-0 DqseC mutant (data not
shown). Another possibility is that RgdR works with the
Pch family of LEE activators (Iyoda and Watanabe, 2004;
Porter et al., 2005; Abe et al. 2008; Yang et al., 2009),
although there is no significant homology between the
two, in particular to the region truncated in the smaller Pch
variants (PchC–E) (Abe et al. 2008). With the exception of
pchD, all pch alleles are encoded on prophage elements,
and it is hypothesized that multiple prophages in the chro-
mosome of EHEC O157:H7 may be able to recombine to
affect the total copy number of pch genes; thus potentially
impacting on levels of LEE gene expression (Ohnishi
et al., 2001; Iyoda and Watanabe, 2004; Asadulghani
et al., 2009). As with the Pch activators of LEE, all
members of the RgdR family of proteins are prophage-
associated. For example, EHEC strain EDL933 harbours
two RgdR truncates (both 63 amino acids), z1197 and
z1636 that are located on OI-43 and OI-48 respectively
(Table S2). In EHEC strain Sakai only one truncate exists
(63 amino acids), ecs5415, which is located on Sakai
prophage-like element 1 (SpLE1). In EHEC O26:H11
strain 11368, four copies of RgdR can be found
(Table S2); three full-length (99 amino acids) variants and
one truncate (63 amino acids) which is located on OI-48.
Perhaps, as proposed for the Pch proteins, genome inte-
gration of CP-933C (OI-51) and similar prophages may
additively influence levels of LEE gene expression in
EHEC. It is therefore perhaps not surprising that a number
of deleted prophage regions analysed in this study and
previously (Tree et al., 2011) have a regulatory impact on
T3S. The RgdR, Pch and Psr families of regulators
provide clear examples of how differences in the proph-
age repertoire of EHEC strains can impact on expression
of critical colonization factors and are a major driving force
in the evolution of this pathogen (Asadulghani et al., 2009;
Tree et al., 2009; 2011).
In summary, this research has defined an important
region (OI-51) necessary for EHEC O157:H7 colonization
and persistence in ruminants, and has identified a com-
pletely new family of small bacterial regulators that control
gene expression in E. coli.
Experimental procedures
Bacterial strains, plasmids and primers
All bacterial strains, plasmids and primers used in this study
are detailed in Table S1.
Bacterial culture conditions and media
Bacterial strains were routinely cultured at 37°C with shaking
in Luria–Bertani (LB) broth or agar. In the analysis of T3S
proteins, either DMEM (Sigma-Aldrich) or MEM-HEPES
(Sigma-Aldrich) supplemented with 250 nM Fe(NO3)2 and
0.2% glucose was used for culturing strains. When measuring
promoter activity with GFP transcriptional fusions, strains
were cultured in DMEM. In Congo red binding assays, CFA
agar (LabM) and CFA broth [0.15% tryptone yeast extract
(Becton Dickinson); 1% casamino acids (Oxoid); 0.01%
Congo red (Sigma-Aldrich); 400 mM MgSO4.7H2O and
40 mM MnCl2.4H2O] was used for selecting and culturing
colonies respectively. When required, Isopropyl b-D-1-
thiogalactopyranoside (IPTG), 5-bromo-4-chloro-3-indolyl-
beta-D-galactopyranoside (X-gal) and antibiotics were added
to media at the following final concentrations: 1 mM IPTG,
20 ng ml-1 X-gal, 50 mg ml-1 ampicillin, 50 mg ml-1 chloram-
phenicol, 100 mg ml-1 kanamycin and 15 mg ml-1 nalidixic acid.
OI-51 ruminant colonization study
Crossbred lambs (six 6-week-old) were housed in bio-secure
containment level 2 accommodation and supplied with food
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and water ad libitum. All lambs were confirmed to be free of
EHEC O157 by enrichment and O157 immuno-magnetic
separation prior to commencing the studies. Lambs were
dosed orally with 1 ¥ 1010 cfu of wild-type E. coli O157:H7
and mutant bacteria (5 ¥ 109 cfu of each). Inocula, 10 ml
resuspended in 10 ml of PBS pH 7.4, were delivered using a
worming gun (Novartis Animal Health) ensuring that the
whole inoculum was delivered directly to the pharynx. Rectal
faecal samples from each lamb were collected daily for direct
plating onto sorbitol-MacConkey (Oxoid) plates supple-
mented with appropriate antibiotics. Enrichment was carried
out on samples in buffered peptone water for 6 h at 37°C and
then plated onto sorbitol-MacConkey plates supplemented
with the appropriate antibiotic. Representative colonies were
confirmed to be E. coli O157 by latex agglutination (Oxoid).
Animal experiments were performed in line with the Animals
Scientific Procedures Act (1986) and were approved by the
local ethical review committee.
Construction of mutations in EHEC and UPEC
Defined ecs1581, c1493 and qseC mutants were con-
structed using allelic exchange as described previously by
Blomfield et al. (1991) and Emmerson et al. (2006). Briefly,
chromosomal regions (~ 600–1000 bp) flanking the genes
of interest were PCR-amplified (Table S1) with a high fide-
lity Phusion polymerase (Fiinzyme) and cloned into a
chloramphenicol-resistant temperature-sensitive exchange
plasmid (pIB073) (Table S1). A kanamycin resistance cas-
sette (Gally et al., 1994) was then cloned in between the
homologous flanking regions on the exchange plasmid and
subjected to several rounds of temperature and antibiotic
selection to achieve allelic replacement in the relevant
strain background. All mutants were verified by PCR and
successful complementation was achieved by providing
the related genes in trans on low copy number plasmid
pWSK29 (Table S1).
Construction of plasmids for expression and
complementation
Complementation plasmids were constructed using PCR
products amplified with high fidelity Phusion polymerase
cloned into pWSK29 (Table S1). E. coli strain DH5a was
used as the intermediate host strain for cloning and all con-
structs were verified by sequencing.
Construction of engineered ECs1581 and ECED1_1787
protein variants
Site-directed mutagenesis was carried out using an overlap
PCR approach with the primers listed in Table S1. Briefly, the
5′ and 3′ regions of each gene were PCR-amplified with
engineered mutations in the relevant primers. The two PCR
products were then used as a template for the overlap PCR
using the outside primers. The PCR products were cloned
into vector pWSK29, verified by sequencing (Table S1), and
their effects on motility and T3S in a TUV93-0 Dec1581
mutant background assessed.
Measurement of LEE1 promoter activity
In order to assess LEE1 gene expression in both wild-type
and mutant E. coli O157:H7 backgrounds, a 428 bp PCR-
generated DNA promoter fragment (-444 to -16 bp upstream
from the ler ATG start codon) was amplified from strain
TUV93-0 using high fidelity Phusion polymerase, and cloned
into the promoter-less green fluorescence protein (GFP)
plasmid pKC26 to create transcriptional fusion plasmid
pLEE1–GFP (Table S1). Test strains harbouring this reporter
were cultured in DMEM supplemented with chloramphenicol
and the GFP produced by each bacterial population was
measured every 60 min by transferring 200 ml aliquots of
culture into triplicate wells in a black 96-well plate (Fluoro-
Nunc) and reading the plate in a fluorimeter (FLUOstar
Optima) using 485 nm absorbance and 520 nm emissions.
Promoter-less plasmid pKC26 in each strain background
acted as a control for auto-fluorescence. When LEE1 pro-
moter activity was measured in response to induced expres-
sion of ecs1581 from low copy number plasmid pWSK29
(pECs1581), strains were cultured in DMEM supplemented
with chloramphenicol, ampicillin and IPTG (1 mM). All were
tested in triplicate and on at least three separate occasions.
Congo red binding assay
Strains were initially streaked onto CFA agar plates (LabM)
before individual colonies were taken and inoculated into
CFA broth and grown overnight at 37°C with shaking. Cul-
tures were diluted in PBS to an OD600 of 1.0, centrifuged at
4000 g for 5 min and resuspended in 1 ml of sterile PBS.
Washing was repeated a further two times to remove all
traces of culture broth before finally resuspending the culture
pellets in 2.5 ml of PBS containing a final concentration of
0.01% Congo red. Samples were incubated at 37°C for
30 min before a 1 ml aliquot was taken and centrifuged at
10 000 g for 10 min. Supernatants were discarded and
pellets were air-dried and photographed using a Lumina
digital camera. All strains were tested in triplicate and on
three separate occasions.
Motility assays
Motility plates were prepared by adding 0.3% agar (Sigma) to
1% Bacto-Tryptone (BD; Becton Dickinson) broth containing
0.5% NaCl (Sigma-Aldrich). For plasmid-based complemen-
tation experiments, IPTG and ampicillin was added to plates
when appropriate and all plates were poured the night before
use and allowed to air-dry on the bench. Plates were stab
inoculated and incubated at 37°C for 16 h. All strains were
tested in triplicate and each experiment was carried out on
three separate occasions.
Adherence assays
Bacteria for the assays were cultured in MEM-HEPES and
added at an moi of approximately 100 bacteria to each epi-
thelial cell. Embryonic bovine lung cells (no.21 ACC192,
German Collection of Microorganisms and Cell Cultures)
were cultured in MEM-HEPES in eight-well chamber slides.
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The cells were washed with PBS and incubated in unsupple-
mented MEM-HEPES for 1 h before they were infected with
bacteria. After 180 min, bacteria and EBL cells were fixed by
incubating in 4% paraformaldehyde for 30 min and then
washed three times with PBS. The samples were incubated
for 90 min with anti-O157 LPS antibody (MAST Group) at
1:4000 and following washes incubated with Alexa Fluor 594-
conjugated goat anti-rabbit immunoglobulins antibody
(1/1000, Molecular Probes) for 1 h. The slides were washed
and mounted (Hydromount, National Diagnostic). Imaging
was carried out using a Leica fluorescence microscope and
Open Lab software (PerkinElmer).
Preparation and analysis of T3S culture supernatant
proteins
Bacterial strains were cultured overnight in LB broth at 37°C
with shaking before being diluted to a starting optical density
(OD600) of 0.05 in MEM-HEPES (supplemented with glucose
and iron). Cultures were grown to a final OD600 of 1.0 then
centrifuged at 4000 g for 30 min at 4°C and supernatants
filtered through 0.45 mm low protein-binding filters (Millipore).
A 10% (v/v) final concentration of trichloroacetic acid (TCA;
Sigma-Aldrich) was used to precipitate the proteins and
BSA (NEB) (4 mg ml-1) was added to act as a co-precipitant.
Supernatants were incubated overnight at 4°C and cen-
trifuged at 4000 g for 30 min at 4°C. Protein pellets were
air-dried and resuspended in an appropriate volume of resus-
pension buffer (1.5 M Tris-HCL) in order to standardize
samples and to take into account the slight variation in OD600
at which cultures were harvested. Culture supernatant pro-
teins were subsequently analysed through a 12% SDS-PAGE
and visualized by Colloidal blue staining (Severn Biotech).
Gel images were captured using a Flowgen MultiImage light
cabinet and ChemiImager 4000i v.4.04 software.
Protein detection
SDS-PAGE separated proteins were transferred onto Hybond
ECL nitrocellulose membrane (Amersham Biosciences)
using a Trans-Blot electrophoretic transfer cell (Bio-Rad).
Nitrocellulose membranes were blocked with 8% (w/v) dried
milk powder (Marvel) in PBS at 4°C overnight and incubated
with the relevant antibodies diluted in wash buffer [1% dried
milk (Marvel) and 0.05% (v/v) polyoxyethylenesorbitan mono-
laurate (Tween 20, Sigma-Aldrich) in PBS] at the following
dilutions: mouse monoclonal anti-EspD (kindly provided by
Professor T. Chakraborty, University of Giessen) and rabbit
polyclonal anti-mouse IgG HRP conjugated antibodies
(Dako) were both diluted 1:4000. All antibody-membrane
incubations were carried out for 1 h at RT on a platform
shaker and were washed for 3 ¥ 10 min in wash buffer before
and after each antibody step. For ECL detection, membranes
were incubated in 2.5 ml of ECL Solution 1 (Amersham)
mixed with 2.5 ml of ECL Solution 2 (Amersham) for 5 min at
RT on the bench. Chemiluminescence was detected on
Hyperfilm ECL chemiluminescence film (Amersham) devel-
oped in a Protec automatic film processor (Optimax). Images
were taken using a Flowgen MultiImage light cabinet and
ChemiImager 4000i v.4.04 software.
Native protein purification
Escherichia coli BL21 (DE3) (Invitrogen) cells harbour-
ing plasmid pET28a-ECs1581, pET28a-ECED1_1787 or
pET28a-ECED1_1787C20R were grown in LB broth in the
presence of kanamycin at 37°C with shaking to an OD600 of 0.5.
Cultures were induced with IPTG and grown for a further 4 h
under the same conditions before harvesting by centrifugation
at 4000 g for 30 min. Cell pellets were suspended in lysis
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole and
1 mg ml-1 lysozyme, pH 8.0) and lysed by sonication (6 ¥ 10 s
pulses with a 10 s cooling period on ice in between each
pulse). Lysates were centrifuged at 10 000 g at 4°C for 30 min,
incubated with Ni2+ NT resin (Qiagen) for 1 h at RT on a
platform shaker and loaded onto a purification column (Bio-
Rad). The column was washed twice with wash buffer (50 mM
NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0) and the
protein was eluted from the column in elution buffer (50 mM
NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0). Crude
preps were transferred into dialysis tubing (8000 kDa molecu-
lar weight cut-off, Medicell international) and dialysed in 2 l of
sterile PBS which was replenished every 24 h for a total of
three changes. Total protein concentration was determined by
BCA according to the manufacturer’s instructions (Novagen)
and purity was verified by SDS-PAGE and antibody detection
of recombinant His-tagged proteins. Purified proteins were
subsequently used in electrophoretic mobility shift and in vitro
transcription assays along with PCR generated DNA promoter
fragments.
Electrophoretic mobility shift assay
To determine if ECs1581 activation of LEE1 is direct or indi-
rect, a 291 bp LEE1 promoter (-288 to +3, with respect to
the ler ATG start codon) and a control gapA fragment (also
291 bp) were PCR-amplified (Table S1) from EHEC strain
TUV93-0 and subjected to EMSA with either purified
ECs1581, ECED1_1787 or ECED1_1787C20R proteins.
EMSA was carried out as described previously (Tree et al.,
2011). Briefly, the purified proteins were co-incubated with
concentrations of ddUTP-11-DIG (Roche) end-labelled DNA
in binding buffer [10 mM Tris (pH 8.0), 50 mM KCl, 5 mM
EDTA, 200 mg ml-1 BSA, 100 ng ml-1 poly d(I-C), 50 mM
glutamate and 5% glycerol] for 30 min at 25°C and loaded
onto 5% non-denaturing polyacrylamide gels in 0.5X TBE.
Fifty nanograms of unlabelled DNA was used for competition
experiments and added to the binding reaction. The DNA and
DNA–protein complexes were electro-transferred onto nylon
membranes and developed with AP-conjugated anti-DIG
antibody (Roche) as per the manufacturer’s instructions.
RT-qPCR
Total RNA was purified from the bacteria using an RNeasy kit
(Qiagen) and random primers used to reverse transcribe the
RNA using Affinityscript (Stratagene). qPCR was carried
out with a PowerSybr mastermix (Applied Biosystems) and
amplified in a MxPro 3000 qPCR machine (Stratagene). The
qPCR primers used are listed in Table S1. Transcript abun-
dance was normalized to 16SrRNA and relative transcription
calculated using MxPro software (Stratagene).
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Bioinformatic analyses
Variants of ECs1581 were identified using BLASTp (http://
www.ncbi.nlm.nih.gov) and sequences were obtained from
GeneBank (http://www.ncbi.nlm.nih.gov/GenBank). Putative
hypothetical domains in ECs1581 were identified using
MyHits (http://myhits.isb-sib.ch/cgi-bin/index) and KEGG
(http://www.genome.jp/kegg). OI-51 prophage alignments
were generated using Easyfig (http://easyfig.sourceforge.
net/). Sequence alignments were performed using ClustalW2
(http://www.ebi.ac.uk/Tools/msa/clustalw2), EMBOSS Align
(http://www.ebi.ac.uk/Tools/emboss/align) and LALIGN
(http://www.ch.embnet.org/software/LALIGN_form.html).
CLC Sequence Viewer (http://www.clcbio.com) was used to
construct and visualize alignments among the protein-coding
regions of ECs1581; the ECs1581 region was identified in
un-annotated draft E. coli sequences through BLASTn
searches.
Sequencing
All DNA sequencing was carried out by GenePool, School of
Biological Sciences, University of Edinburgh, and was per-
formed using an ABI Prism BigDye terminator cycle sequenc-
ing kit version 3.1 (Applied Biosystems). Reactions were
analysed on an ABI 3730 DNA sequencer.
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